CONMED (CNMD) vs Globus Medical (GMED)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Globus Medical (GMED) has outperformed CONMED (CNMD) over the past year, gaining 25.2% versus a loss of 2.2%. Over five years, GMED leads with a -2.3% price change compared with -68.7% for CNMD. Globus Medical is the larger company by market cap ($10.02 billion vs $1.33 billion), about 7.5 times the size.
On valuation, CONMED trades at a lower forward P/E (9.3x vs 13.8x for Globus Medical). CONMED pays a dividend yielding 0.45%, while Globus Medical does not currently pay one. Globus Medical converts more of its revenue into profit, with a net margin of 18.3% versus 3.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNMD | GMED |
|---|---|---|
| Share price | $44.42 | $74.65 |
| Market cap | $1.33B | $10.02B |
| 1-day change | -1.53% | +1.80% |
| YTD return | +9.41% | -14.50% |
| 1-year return | -2.18% | +25.23% |
| 5-year return | -68.72% | -2.33% |
| P/E ratio (TTM) | 24.01 | 19.14 |
| Forward P/E | 9.29 | 13.83 |
| EPS (TTM) | $1.85 | $3.90 |
| Dividend yield | 0.45% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| Revenue (latest FY) | $1.37B | $2.94B |
| Revenue growth (YoY) | +5.18% | +16.65% |
| Net income (latest FY) | $47.05M | $537.87M |
| Gross margin | 54.59% | 67.41% |
| Operating margin | 7.46% | 16.33% |
| Net margin | 3.42% | 18.30% |
| 52-week high | $53.66 | $101.40 |
| 52-week low | $31.44 | $56.66 |
| Distance from 52-week high | -17.22% | -26.38% |
| Analyst consensus | none | buy |
| Avg. price target upside | +2.43% | +35.19% |
| Average volume | 482.58K | 1.51M |
| Shares outstanding | 29.95M | 111.83M |
| Employees | 3,900 | 6,000 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Globus Medical is about 7.5 times larger than CONMED by market value ($10.02B vs $1.33B).
- GMED has outperformed CNMD by 27.4 percentage points over the past year.
- CONMED trades at a higher earnings multiple (24.0x vs 19.1x trailing P/E).
- Globus Medical is more profitable, keeping 18.3 cents of every revenue dollar as net income versus 3.4 cents for CONMED.
- Globus Medical grew revenue faster in its latest fiscal year (+16.65% vs +5.18%).
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as powered resection instruments, fluid management and visualization systems, and related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Healthcare · Medical Devices · 3,900 employees
About Globus Medical
GMED stock →Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
Healthcare · Medical Devices · 6,000 employees
CNMD vs GMED FAQ
Which is bigger, CONMED or Globus Medical?
Globus Medical (GMED) is larger, with a market capitalization of $10.02B compared with $1.33B for CONMED (CNMD).
Which stock has performed better over the past year, CNMD or GMED?
GMED returned +25.23% over the past 12 months, compared with -2.18% for CNMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CNMD or GMED?
GMED has the lower trailing P/E at 19.1, versus 24.0 for CNMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, CONMED or Globus Medical?
CONMED pays a dividend yielding 0.45%, while Globus Medical does not currently pay a regular dividend.
Are CONMED and Globus Medical in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.